Mertigo SR sustained-release tablets

Dexa Medica

Ingredients in every sustained-release tablet

Betahistine 12 mg

Each package contains

10 strips of 10 sustained-release tablets

Other details

Dosage form:Tablet; coated; sustained-release
Flavour None

W.H.O. classification

ATC Level 1 N - Nervous system
ATC Level 2 N07 - Other Nervous System Drugs in ATC
ATC Level 3 N07C - Antivertigo Preparations

Warnings

Pregnancy

CAUTIONThis item may not be safe for use during pregnancy. Use with caution and after consultation with your doctor.

Lactation

CONSULT YOUR DOCTORSafety of this item for use during lactation has not been established. Please consult your doctor.

Alcohol

CONSULT YOUR DOCTORSafety of this item for use with alcohol has not been established. Please consult your doctor.

Machinery

SAFE IF PRESCRIBEDThis item is safe for use while operating heavy machinery.

Available in

Indonesia

Dosage information

18 YEARS OLD AND ABOVE
1 sustained-release tablet (12 mg of betahistine mesylate) twice daily, taken orally after each meal. Betahistine mesylate sustained-release tablet must be swallowed whole and never crushed or chewed.

Indication

To relieve vertigo, dizziness which related to vestibular disorder in blood circulation disorder or Meniere’s syndrome, Meniere’s disease, and peripheral vertigo.